In ovarian cancer (OV), head and neck squamous (HNSC) cell carcinoma and low-grade glioma (LGG), low levels of SETX expression did not correlate with a poorer prognosis in the tested cohorts (Fig. 6A). This evidence concerns the gene SETX and central nervous system cancer.